These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17200040)

  • 21. Vitamin D and cardiovascular prevention.
    Nadir MA; Szwejkowski BR; Witham MD
    Cardiovasc Ther; 2010 Aug; 28(4):e5-12. PubMed ID: 20553279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.
    St Peter WL; Li S; Liu J; Gilbertson DT; Arneson TJ; Collins AJ
    Pharmacotherapy; 2009 Feb; 29(2):154-64. PubMed ID: 19170585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ; Slatopolsky E
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease.
    Raggi P; Kleerekoper M
    Clin J Am Soc Nephrol; 2008 May; 3(3):836-43. PubMed ID: 18322050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D in kidney disease: pathophysiology and the utility of treatment.
    Qazi RA; Martin KJ
    Endocrinol Metab Clin North Am; 2010 Jun; 39(2):355-63, table of contents. PubMed ID: 20511057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
    Brown AJ; Slatopolsky E
    Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new role for vitamin D receptor activation in chronic kidney disease.
    Valdivielso JM; Cannata-Andía J; Coll B; Fernández E
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1502-9. PubMed ID: 19625376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardioprotective effect of vitamin D in nondialyzed patients with stage 3-5 CKD].
    Cozzolino M; Mehmeti F; Bonelli F; Ronga C; Musetti C; Missaglia E; Stucchi A; Colombo F; Tavecchia M; Cuoccio P; Brenna I; Volpi E; Ciceri P; Cusi D
    G Ital Nefrol; 2010; 27 Suppl 52():S27-31. PubMed ID: 21132659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When is Vitamin D contraindicated in dialysis patients?
    Evenepoel P
    Semin Dial; 2009; 22(3):242-4. PubMed ID: 19572999
    [No Abstract]   [Full Text] [Related]  

  • 30. Vitamin D receptor activation and cardiovascular disease.
    Gonzalez-Parra E; Rojas-Rivera J; Tuñón J; Praga M; Ortiz A; Egido J
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv17-21. PubMed ID: 23258805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulating effects of vitamin D analogs in hemodialysis patients.
    Seibert E; Levin NW; Kuhlmann MK
    Hemodial Int; 2005 Oct; 9 Suppl 1():S25-9. PubMed ID: 16223440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use (or misuse) of vitamin D treatment in CKD and dialysis patients: A recent meta-analysis on vitamin D compounds in chronic kidney disease [1] and an editorial comment [2] accompanying this meta-analysis have already been published. We believe that these papers deserve some comments in the interest of the NDT readership.
    Olgaard K; Lewin E
    Nephrol Dial Transplant; 2008 Jun; 23(6):1786-9; discussion 1789-3. PubMed ID: 18400819
    [No Abstract]   [Full Text] [Related]  

  • 33. Vitamin D deficiency masking primary hyperparathyroidism.
    Hannan FM; Fairney A; Johnston DG
    Ann Clin Biochem; 2004 Sep; 41(Pt 5):405-7. PubMed ID: 15333193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Making sense of the latest advice on vitamin D therapy.
    Monk RD; Bushinsky DA
    J Am Soc Nephrol; 2011 Jun; 22(6):994-8. PubMed ID: 21617120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
    Choi M; Makishima M
    Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vitamin D and chronic kidney disease: increasing role for an old vitamin].
    Ernandez T; Stoermann-Chopard C
    Rev Med Suisse; 2012 Nov; 8(361):2140-5. PubMed ID: 23173351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs.
    Brancaccio D; Cozzolino M; Galassi A; Chiarelli G; Butti A; Bellasi A; Rocca-Rey L; Volpi A; Anelli A; Zoni U; Fusaro M; Brambilla C; Missaglia E; Crovetto C; Russo M; Longhini C; Provenzano R; Incalcaterra F; Cerasola G; Li Vecchi M; Gallieni M
    J Nephrol; 2007; 20(1):3-9. PubMed ID: 17347966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D deficiency and cardiovascular disease: Is there a role for vitamin D therapy in heart failure?
    Lee W; Kang PM
    Curr Opin Investig Drugs; 2010 Mar; 11(3):309-14. PubMed ID: 20178044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D in solid organ transplantation with special emphasis on kidney transplantation.
    Thiem U; Borchhardt K
    Vitam Horm; 2011; 86():429-68. PubMed ID: 21419283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical aspects of vitamin D in the management of rheumatoid arthritis.
    Leventis P; Patel S
    Rheumatology (Oxford); 2008 Nov; 47(11):1617-21. PubMed ID: 18682414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.